The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance.
cancer
miR-7
multidrug resistance
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
12 Feb 2021
12 Feb 2021
Historique:
received:
15
01
2021
revised:
08
02
2021
accepted:
09
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
MicroRNAs (miRNAs, miRs) are small non-coding RNA (ncRNA) molecules capable of regulating post-transcriptional gene expression. Imbalances in the miRNA network have been associated with the development of many pathological conditions and diseases, including cancer. Recently, miRNAs have also been linked to the phenomenon of multidrug resistance (MDR). MiR-7 is one of the extensively studied miRNAs and its role in cancer progression and MDR modulation has been highlighted. MiR-7 is engaged in multiple cellular pathways and acts as a tumor suppressor in the majority of human neoplasia. Its depletion limits the effectiveness of anti-cancer therapies, while its restoration sensitizes cells to the administered drugs. Therefore, miR-7 might be considered as a potential adjuvant agent, which can increase the efficiency of standard chemotherapeutics.
Identifiants
pubmed: 33673265
pii: ph14020149
doi: 10.3390/ph14020149
pmc: PMC7918072
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : National Science Centre
ID : grant No. 2018/29/B/NZ3/02642 to M.G.1
Organisme : Centre of Postgraduate Medical Education
ID : PhD program funds No. 506-1-025-01-20 to E.G., D.G.
Références
Cancer Cell Int. 2017 Feb 21;17:31
pubmed: 28239300
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
Genes Dev. 2013 Jan 1;27(1):24-38
pubmed: 23307866
Onco Targets Ther. 2017 Apr 07;10:2045-2056
pubmed: 28435295
Theranostics. 2017 Sep 22;7(17):4118-4134
pubmed: 29158814
Cell Biosci. 2020 Jun 10;10:77
pubmed: 32537124
Gene Expr Patterns. 2009 Apr;9(4):193-9
pubmed: 19135553
Med Sci Monit. 2018 Sep 16;24:6506-6516
pubmed: 30219819
Mol Cancer. 2015 Mar 12;14:59
pubmed: 25880778
Oncotarget. 2014 Aug 30;5(16):6687-700
pubmed: 25149532
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820957023
pubmed: 32910747
Nanomaterials (Basel). 2019 Apr 18;9(4):
pubmed: 31003512
Nucleic Acids Res. 2006;34(20):5863-71
pubmed: 17062625
Exp Dermatol. 2020 Apr;29(4):376-379
pubmed: 32012357
Nat Rev Cancer. 2009 Sep;9(9):631-43
pubmed: 19701242
J Pathol. 2005 Jan;205(2):275-92
pubmed: 15641020
Dev Biol. 2009 Feb 15;326(2):431-43
pubmed: 19073166
Adv Pharm Bull. 2017 Sep;7(3):339-348
pubmed: 29071215
Cell Mol Gastroenterol Hepatol. 2020;9(3):447-464
pubmed: 31756561
FEBS Open Bio. 2020 Jul;10(7):1230-1237
pubmed: 32175684
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6942-6950
pubmed: 32139605
Nat Rev Mol Cell Biol. 2019 Jan;20(1):5-20
pubmed: 30228348
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C366-C374
pubmed: 31166710
Mol Cell. 2010 Apr 9;38(1):67-77
pubmed: 20385090
J Cell Physiol. 2019 Aug;234(10):17494-17504
pubmed: 30912129
Semin Cancer Biol. 2020 Jul 27;:
pubmed: 32730814
Cell Cycle. 2019 Nov;18(21):2939-2953
pubmed: 31522588
J Control Release. 2019 Aug 10;307:331-341
pubmed: 31238049
Oncol Lett. 2019 Mar;17(3):3241-3246
pubmed: 30867755
Contemp Oncol (Pozn). 2015;19(3):201-6
pubmed: 26557760
Int J Biochem Cell Biol. 2015 Dec;69:215-24
pubmed: 26546742
Mol Cell Biol. 2008 Apr;28(7):2167-74
pubmed: 18212054
PLoS One. 2014 Dec 22;9(12):e114419
pubmed: 25532106
Int J Mol Sci. 2020 Jul 17;21(14):
pubmed: 32708846
Mol Cell Probes. 2017 Aug;34:45-52
pubmed: 28546132
Nucleic Acids Res. 2019 Apr 23;47(7):3353-3364
pubmed: 30820533
Tumour Biol. 2014 Oct;35(10):10177-84
pubmed: 25027403
Biomed Res Int. 2020 Jun 21;2020:9875636
pubmed: 32685551
Int J Clin Exp Pathol. 2017 Aug 01;10(8):9035-9041
pubmed: 31966774
Mol Ther Nucleic Acids. 2018 Dec 7;13:121-132
pubmed: 30290304
Biochem Biophys Res Commun. 2019 Jun 18;514(1):231-238
pubmed: 31029422
Carcinogenesis. 2015 Mar;36(3):338-45
pubmed: 25503932
Mol Cell Biol. 2013 Mar;33(6):1233-43
pubmed: 23319046
Cancer Cell Int. 2020 Feb 18;20:54
pubmed: 32099527
Apoptosis. 2016 Mar;21(3):312-28
pubmed: 26573275
Am J Transl Res. 2016 Feb 15;8(2):993-1004
pubmed: 27158385
Aliment Pharmacol Ther. 2016 Jan;43(1):102-13
pubmed: 26503793
Mol Cell. 2009 Sep 11;35(5):610-25
pubmed: 19748357
J Hepatocell Carcinoma. 2016 Oct 05;3:41-53
pubmed: 27785449
Cancer Res. 2010 Nov 1;70(21):8822-31
pubmed: 20978205
Int J Mol Sci. 2016 Oct 13;17(10):
pubmed: 27754357
Cell Physiol Biochem. 2017;42(2):660-672
pubmed: 28618418
Stem Cells. 2014 Nov;32(11):2858-68
pubmed: 25070049
Cancer Cell Int. 2020 Jul 22;20:334
pubmed: 32714093
Cell Cycle. 2020 Oct;19(19):2496-2508
pubmed: 32931357
Mol Cancer. 2018 Feb 19;17(1):25
pubmed: 29455646
Breast Cancer Res Treat. 2017 Apr;162(3):511-521
pubmed: 28181130
Drug Resist Updat. 2020 May;50:100682
pubmed: 32087558
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
World J Gastroenterol. 2018 Mar 7;24(9):1004-1012
pubmed: 29531464
Cell Biosci. 2019 Nov 12;9:91
pubmed: 31749959
Cell Transplant. 2012;21(8):1761-74
pubmed: 22186137
Mol Ther Nucleic Acids. 2018 Sep 7;12:490-503
pubmed: 30195786
Cancer Cell Int. 2020 Jul 23;20:335
pubmed: 32714094
Cancer Cell Int. 2015 Oct 29;15:103
pubmed: 26516313
Transl Cancer Res. 2018 Jun;7(Suppl 5):S624-S628
pubmed: 30159229
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
J Cell Physiol. 2018 Dec;233(12):9503-9515
pubmed: 29968912
Adv Exp Med Biol. 2007;608:1-22
pubmed: 17993229
Cell. 1993 Dec 3;75(5):855-62
pubmed: 8252622
Mol Neurobiol. 2016 Dec;53(10):7057-7069
pubmed: 26676570
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):372-378
pubmed: 28986256
J Neuroinflammation. 2020 Jan 20;17(1):28
pubmed: 31959187
Front Endocrinol (Lausanne). 2019 Apr 08;10:207
pubmed: 31024447
Hepatology. 2014 Nov;60(5):1607-19
pubmed: 24752868
Mol Ther Nucleic Acids. 2019 Sep 6;17:374-387
pubmed: 31302497
Int J Cancer. 2010 Oct 15;127(8):1785-94
pubmed: 20099276
World J Biol Chem. 2017 Feb 26;8(1):45-56
pubmed: 28289518
Hepatology. 2018 Jan;67(1):216-231
pubmed: 28833396
Cancer Res. 2008 Oct 15;68(20):8195-200
pubmed: 18922890
Onco Targets Ther. 2019 Dec 16;12:11097-11105
pubmed: 31908478
Environ Toxicol Chem. 2014 Mar;33(3):481-92
pubmed: 24273100
J Clin Med. 2015 Aug 25;4(9):1668-87
pubmed: 26308064
Biochem Biophys Res Commun. 2010 Apr 16;394(4):921-7
pubmed: 20230785
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
J Cell Mol Med. 2018 Jun;22(6):3097-3107
pubmed: 29532994
Aging (Albany NY). 2018 Jun 28;10(6):1281-1293
pubmed: 29953413
Mol Carcinog. 2019 Apr;58(4):554-564
pubmed: 30520151
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5597-5604
pubmed: 30229834
IET Syst Biol. 2019 Oct;13(5):225-233
pubmed: 31538956
Cancer Sci. 2003 Jan;94(1):15-21
pubmed: 12708468
Biomed Pharmacother. 2020 Jan;121:109628
pubmed: 31731190
Int J Exp Pathol. 2015 Aug;96(4):240-7
pubmed: 26108539
Int J Mol Sci. 2016 Dec 22;18(1):
pubmed: 28025496
Circ Res. 2019 Jun 21;125(1):14-25
pubmed: 30964391
Cancer Lett. 2015 Mar 1;358(1):27-36
pubmed: 25511742
Front Oncol. 2019 Sep 26;9:963
pubmed: 31616641
Exp Cell Res. 2019 Feb 1;375(1):73-81
pubmed: 30586549
Exp Cell Res. 2018 Jul 15;368(2):194-201
pubmed: 29723509
Trends Biotechnol. 2012 Apr;30(4):185-90
pubmed: 22260747
J Clin Neurosci. 2015 Aug;22(8):1254-7
pubmed: 25882257
EMBO J. 2012 Aug 29;31(17):3513-23
pubmed: 22773185
Oncotarget. 2016 May 31;7(22):31663-80
pubmed: 27203220
Chin J Cancer. 2012 Feb;31(2):51-7
pubmed: 22257384
Technol Cancer Res Treat. 2017 Dec;16(6):1022-1030
pubmed: 28693382
Evol Bioinform Online. 2014 Jul 14;10:107-13
pubmed: 25089088
ACS Appl Mater Interfaces. 2018 Mar 7;10(9):7821-7831
pubmed: 29411964
J Cell Biol. 2015 Aug 17;210(4):613-27
pubmed: 26261179
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2285-95
pubmed: 27338053
Cancer Biol Ther. 2019;20(1):73-80
pubmed: 30207835
J Cell Physiol. 2019 Jun;234(6):9144-9155
pubmed: 30341906
Cell Stem Cell. 2010 May 7;6(5):433-44
pubmed: 20452318
J Cell Sci. 2007 Sep 1;120(Pt 17):3045-52
pubmed: 17715156
J Neuroimmune Pharmacol. 2020 Sep;15(3):538-553
pubmed: 31401755
J Mammary Gland Biol Neoplasia. 2019 Dec;24(4):323-331
pubmed: 31776835
Int J Biochem Cell Biol. 2014 Sep;54:312-7
pubmed: 24907395
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5285-5292
pubmed: 31298380
Oncol Lett. 2019 Feb;17(2):1819-1825
pubmed: 30675243
Nucleic Acids Res. 2008 Sep;36(16):5391-404
pubmed: 18701644
J Surg Res. 2019 Aug;240:48-59
pubmed: 30909065
J Cancer. 2019 Aug 27;10(20):4793-4806
pubmed: 31598150
Mol Oncol. 2014 Mar;8(2):417-30
pubmed: 24412053
BMC Cancer. 2019 Jun 18;19(1):602
pubmed: 31215481
Genes Dis. 2018 May 12;5(2):77-106
pubmed: 30258937
Int J Biol Sci. 2011;7(6):805-14
pubmed: 21750649
Oncotarget. 2016 Aug 16;7(33):53558-53570
pubmed: 27448964
Mol Ther Oncolytics. 2020 Jun 04;18:70-82
pubmed: 32637582
Oncol Lett. 2014 Nov;8(5):2193-2200
pubmed: 25289099
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819898728
pubmed: 31960764
Cell Cycle. 2010 May;9(9):1809-18
pubmed: 20404570
IUBMB Life. 2020 May;72(5):855-871
pubmed: 31913572
Trends Mol Med. 2017 Aug;23(8):721-736
pubmed: 28694140
Diabetes. 2013 Mar;62(3):887-95
pubmed: 23223022
J Cell Mol Med. 2019 Aug;23(8):4921-4932
pubmed: 31245927
Cell. 2018 Jul 12;174(2):350-362.e17
pubmed: 29887379
J Surg Sci. 2013 Dec;1(1):3-7
pubmed: 24818173
Chin J Cancer. 2011 Jun;30(6):371-80
pubmed: 21627859
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Oncotarget. 2015 Nov 10;6(35):37965-78
pubmed: 26513016
Ann Transl Med. 2020 Apr;8(7):499
pubmed: 32395543
Cell Mol Biol Lett. 2019 Nov 20;24:60
pubmed: 31832068
Cells. 2020 Jan 23;9(2):
pubmed: 31979244
Epigenomics. 2017 Sep;9(9):1175-1188
pubmed: 28803498
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
Proc Biol Sci. 2018 Sep 26;285(1887):
pubmed: 30257913
J Biol Chem. 2011 Jul 15;286(28):25377-86
pubmed: 21592959
Onco Targets Ther. 2014 Feb 20;7:325-32
pubmed: 24570594
Sci Rep. 2018 Jun 25;8(1):9657
pubmed: 29941867
Methods Mol Biol. 2018;1819:75-92
pubmed: 30421400
BMC Res Notes. 2019 Sep 23;12(1):605
pubmed: 31547858
Mol Med Rep. 2019 Oct;20(4):3463-3474
pubmed: 31485661
Oncogene. 2012 Feb 23;31(8):1045-54
pubmed: 21743493
Circ Res. 2020 Feb 28;126(5):663-678
pubmed: 32105576
Oncol Lett. 2016 Dec;12(6):4613-4617
pubmed: 28105168
Expert Opin Drug Discov. 2020 Sep;15(9):987-992
pubmed: 32421364
Eur J Cancer. 2010 Jun;46(9):1692-702
pubmed: 20371173
Ann Transl Med. 2018 Apr;6(8):145
pubmed: 29862234
Mol Med Rep. 2015 Jan;11(1):333-40
pubmed: 25339453
J Neurosci. 2014 Sep 17;34(38):12725-37
pubmed: 25232110
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2400-2406
pubmed: 29966655
Cells. 2019 Nov 19;8(11):
pubmed: 31752361
Cells. 2020 Jul 06;9(7):
pubmed: 32640511
Dis Markers. 2020 Jun 1;2020:2782101
pubmed: 32566037
Mol Cell. 2010 Jul 9;39(1):133-44
pubmed: 20603081
Nat Cell Biol. 2019 May;21(5):542-551
pubmed: 31048766
J Gastroenterol. 2020 Jan;55(1):51-66
pubmed: 31562534
PLoS One. 2012;7(8):e41523
pubmed: 22876288
Int J Clin Exp Pathol. 2015 Aug 01;8(8):9072-80
pubmed: 26464649
Transl Lung Cancer Res. 2016 Jun;5(3):288-300
pubmed: 27413711